Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study

Edoardo Mazzucchi; Giada Pauletto; Giovanni Sabatino; Tamara Ius

doi:10.1212/WNL.0000000000200900

Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study

Edoardo Mazzucchi, Giada Pauletto, Giovanni Sabatino, Tamara Ius

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

We read with interest the article by Pallud et al.(1) in which patients with isocitrate dehydrogenase wild-type glioma who took levetiracetam during the whole standard chemoradiation protocol experienced relevant improvement in survival.

Lingua originale	English
pagine (da-a)	84-85
Numero di pagine	2
Rivista	Neurology
Volume	99
DOI	https://doi.org/10.1212/WNL.0000000000200900
Stato di pubblicazione	Pubblicato - 2022

Keywords

Levetiracetam

Accesso al documento

10.1212/WNL.0000000000200900

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{ed160eae325044d5b9a92b59e3e680d8,

title = "Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study",

abstract = "We read with interest the article by Pallud et al.(1) in which patients with isocitrate dehydrogenase wild-type glioma who took levetiracetam during the whole standard chemoradiation protocol experienced relevant improvement in survival.",

keywords = "Levetiracetam, Levetiracetam",

author = "Edoardo Mazzucchi and Giada Pauletto and Giovanni Sabatino and Tamara Ius",

year = "2022",

doi = "10.1212/WNL.0000000000200900",

language = "English",

volume = "99",

pages = "84--85",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study

AU - Mazzucchi, Edoardo

AU - Pauletto, Giada

AU - Sabatino, Giovanni

AU - Ius, Tamara

PY - 2022

Y1 - 2022

N2 - We read with interest the article by Pallud et al.(1) in which patients with isocitrate dehydrogenase wild-type glioma who took levetiracetam during the whole standard chemoradiation protocol experienced relevant improvement in survival.

AB - We read with interest the article by Pallud et al.(1) in which patients with isocitrate dehydrogenase wild-type glioma who took levetiracetam during the whole standard chemoradiation protocol experienced relevant improvement in survival.

KW - Levetiracetam

UR - http://hdl.handle.net/10807/302798

U2 - 10.1212/WNL.0000000000200900

DO - 10.1212/WNL.0000000000200900

M3 - Article

SN - 0028-3878

VL - 99

SP - 84

EP - 85

JO - Neurology

JF - Neurology

ER -

Reader Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo